Smith & Nephew PLC
NPW1
Company Profile
Business description
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.
Contact
Hatters Lane
Building 5, Croxley Park
WatfordHertfordshireWD18 8YE
GBRT: +44 1923477100
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
17,000
Stocks News & Analysis
stocks
ASX data centre share forecasts AI fuelled earnings surge
AI and cloud demand underpin bullish growth outlook
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,260.90 | 40.40 | 0.44% |
| CAC 40 | 8,301.85 | 32.65 | -0.39% |
| DAX 40 | 25,970.11 | 288.00 | -1.10% |
| Dow JONES (US) | 52,916.89 | 269.01 | -0.51% |
| FTSE 100 | 10,789.28 | 34.98 | -0.32% |
| HKSE | 25,329.73 | 237.26 | -0.93% |
| NASDAQ | 26,166.61 | 204.28 | -0.77% |
| Nikkei 225 | 66,215.34 | 96.59 | -0.15% |
| NZX 50 Index | 13,786.90 | 130.40 | -0.94% |
| S&P 500 | 7,646.77 | 39.37 | -0.51% |
| S&P/ASX 200 | 9,066.70 | 41.70 | 0.46% |
| SSE Composite Index | 3,979.89 | 6.41 | -0.16% |